[Experimental study of therapeutic time window of L-serine against focal cerebral ischemia/reperfusion injury in rats]

Zhongguo Ying Yong Sheng Li Xue Za Zhi. 2010 Feb;26(1):72-6.
[Article in Chinese]

Abstract

Objective: To observe the therapeutic time window of L-serine against focal cerebral ischemia/reperfusion injury in rats, and related mechanisms.

Methods: Sprague-Dawley rats were randomly divided into six groups (n=6), sham-operation group, vehicle group, 3, 6, 12 and 24 h treatment group of L-serine. Focal cerebral ischemia was induced with the method of middle cerebral artery occlusion (MCAO) in rats, and reperfusion was emerged by removing the thread 2 h later. The treatment of L-serine (200 mg/kg ip) was begun at 3, 6, 12 and 24 h after MCAO respectively, and subsequently repeated once 12 h. The vehicle group was intraperitoneally injected with isodose normal saline. The neurological behavior score and cerebral infarction volume was measured 48 h after reperfusion. In addition, the contents of malondialdehyde (MDA), activity of superoxide dismetase (SOD), the levels of inflammatory cytokines (TNF-alpha, IL-6) and ultrastructure of neuron in brain tissue were investigated.

Results: Compared with the vehicle group, treatments with L-serine both 3 and 6 h after MCAO decreased the neurology deficit score and infarct volume. Only neurology deficit score had been reduced 12 h after MCAO, while no neuropmrotective effects had been observed during 24 h. Furthermore, L-serine elevated the content of SOD, decreased the level of MDA, TNF-alpha and IL-6 in ischemic brain tissue, and alleviated the injury of the neuronal ultrastructure.

Conclusion: L-serine exerted a time-dependent neuroprotective effect on the brain after MCAO in rat. This effect might be possibly mediated through following mechanisms: lessening oxidative stress and reducing the release of inflammatory cytokines.

Publication types

  • English Abstract
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Brain Ischemia / drug therapy
  • Brain Ischemia / pathology
  • Brain Ischemia / physiopathology*
  • Interleukin-6 / metabolism
  • Male
  • Neuroprotective Agents / therapeutic use*
  • Oxidative Stress / drug effects
  • Rats
  • Rats, Sprague-Dawley
  • Reperfusion Injury / prevention & control*
  • Serine / therapeutic use*
  • Superoxide Dismutase / metabolism
  • Time Factors
  • Tumor Necrosis Factor-alpha / metabolism

Substances

  • Interleukin-6
  • Neuroprotective Agents
  • Tumor Necrosis Factor-alpha
  • Serine
  • Superoxide Dismutase